Recent content by sharesontoast

Here is today's ANN Phylogica exceeds gold-standard for treatment of MYC-driven cancer More than 7 in 10 cancer cases depend on the mutant gene MYC for survival1. While recognised as an important cancer target, there are currently no effective MYC therapies available. This is due primarily...

Here is the link to todays release: Phylogica’s intracellular targeting drug achieves significant reduction in tumours in animal model of cancer...

Here is today's release from ProactiveInvestors titled: 'Phylogica has big six months ahead' http://www.proactiveinvestors.com.au/companies/news/64933/phylogica-has-big-six-months-ahead-64933.html SoT DYOR

This link is to the latest radio interview with PYC's CEO. Cheers https://audioboom.com/boos/3581128-dr-richard-hopkins-phylogica

Article discussing PYCs science: 'Telethon Institute closes in on cancer treatments holy grail' https://au.news.yahoo.com/thewest/full-coverage/empowering-innovation/a/29499490/telethon-institute-closes-on-cancer-treatment-s-holy-grail/

Re: PYC - Killing Cancer From The Inside This link is to a video interview with CEO Dr Richard Hopkins on 9 April 2015 Cheers SoT https://www.youtube.com/watch?v=1lXbGwQ_YWQ

Today's ANN sees PYC jockeying into a commanding position in the drug development of the intracellular space. Till now we have seen PYC developing: - cell-penetrating peptides and peptide drug molecules targeting intracellular 'transcription factors'. - cell-penetrating peptides with...

Today's ANN: Phylogica enters transaction with UK biotech to identify and develop small molecule cancer drugs • Non-exclusive license granted to PhoreMost Limited for phenotypic screening of Phylomer libraries to discover and develop small molecule drugs • Phylogica obtains 7.5% stake in...

PYC - Killing Cancer From The Inside This morning's press release: Phylogica Peptide Fusion Kills Aggressive Breast Cancer Cells • Phylogica’s peptide fusions kill aggressive, drug resistant breast cancer cells • Phylomer peptide fusions significantly boost potency of cancer drugs • In...

PYC - Killing Cancer From The Inside Here is a news.com article titled 'Killing Cancer From the Inside' which explains Phylogica's current science. http://www.news.com.au/finance/business/killing-cancer-from-the-inside/story-e6frfkur-1227250810221 Also this mornings herald/sun article...

RBS Morgans give PYC a BUY rating following the latest deal with Janssen (a Johnson and Johnson company). http://www.phylogica.com/media/articles/In...majorpharma.pdf

Phylogica The following link is titled 'Roche seeks 'Targeted Acquistions' not Abbott sized deal'. PYC is not mentioned in the article (and much is said of Abbott) but the following paragraph from Roche's CEO is interesting: "We've focused on smaller, bolt-on acquisitions," Schwan said...

The following link is a BRW must read, titled 'Value In Biotechs'. PYC is one of three bios covered in the article. Cheers ST http://www.phylogica.com/media/articles/Investors---Investor-Presentations/20110920-Value-in-Biotech-637/110915BRW-ValueinBiotech-Patrys.pdf

Hi nngn, Fancy meeting you here:) ....................... Just a few powerful 3rd party quotes concerning PYC over the last 12mths: "We scour the world looking for innovation that could lead to new medicines, and our collaboration with Phylogica has uncovered an exciting area of...

Not to late to be in For a company with a 20m market cap, PYC has a lot of big pharma friends. Roche, AstraZeneca and Pfizer are sitting at PYCs table. Another 3 big pharma are expected in the next 12mths. PYCs sp hasn't been responding to their outstanding progress over the last few...